Although the major drug development regions of the world are recognized to be North America, Europe and Japan, continuing growth of the pharmaceutical market into emerging regions is being accompanied by similar growth in clinical trial activity outside the traditional “big three” markets.
Stuart Mudge
2005 – Australian Biotechnology News
All our Resources
blog
Have you ever asked yourself how, as a patient, you would react if your physician proposed you to participate in…
blog
2024 is here and will be a crucial year for your clinical trials in the European Union (EU) and European…
blog
The adoption of Electronic Patient-Reported Outcomes (ePRO) in clinical research marks a significant evolution in the way patient-centered data is…
webinar
Embracing an Early Access Program (EAP) presents a strategic avenue for creating valuable opportunities for patients and companies. This webinar…
